In an adult with uncomplicated primary hypertension who is already on a stable antihypertensive regimen and not taking nitrate‑containing agents, is beetroot powder a viable adjunctive supplement for blood pressure management?

Beetroot Powder as an Adjunctive Supplement for Hypertension Management

Beetroot powder is NOT recommended as a standard adjunctive supplement for hypertension management in adults already on stable antihypertensive therapy, as it is not mentioned in any major hypertension guidelines and lacks sufficient evidence for clinically meaningful blood pressure reduction in treated hypertensive patients.

Guideline-Based Recommendations

The most recent and authoritative hypertension guidelines—the 2024 ESC Guidelines 1 and 2025 AHA/ACC Guidelines 2—provide comprehensive lifestyle modification recommendations but do not include beetroot juice or beetroot powder among recommended interventions.

What Guidelines Actually Recommend for Lifestyle Modifications:

First-line lifestyle interventions with strong evidence 2:

• Sodium reduction to <2,300 mg/day (ideally <1,500 mg/day) - Class I, Level A
• Potassium supplementation (3,500-5,000 mg/day from dietary sources) - Class I, Level A
• Weight loss for those with BMI ≥25 kg/m² - Class I, Level A
• DASH diet (Dietary Approaches to Stop Hypertension) - Class I, Level A
• Regular aerobic exercise (≥150 minutes/week moderate intensity) - Class I, Level A
• Alcohol limitation (≤2 drinks/day for men, ≤1 for women) - Class I, Level A

The 2020 ISH Guidelines 3 mention increasing intake of "vegetables high in nitrates known to reduce BP, such as leafy vegetables and beetroot" as part of a healthy diet pattern, but this is embedded within general dietary advice, not as a specific supplement recommendation.

Research Evidence: Mixed and Insufficient

While research studies show some blood pressure effects from beetroot juice, the evidence has critical limitations:

Modest Effects in Hypertensive Populations:

The most recent meta-analysis 4 (2024) in diagnosed hypertensive patients (BP ≥140/90 mmHg per ESC criteria) found:

• Systolic BP reduction: -5.31 mmHg (95% CI: -7.46 to -3.16)
• No significant effect on diastolic BP
• Moderate to high heterogeneity between studies
• Low certainty of evidence (GRADE ⊕⊕OO)

Another meta-analysis 5 (2022) showed similar modest effects: -4.95 mmHg systolic (no diastolic effect), also with moderate certainty.

Critical Limitation - Failure in Treated Hypertensive Patients:

The most clinically relevant study 6 (2015) directly tested your scenario: a randomized, placebo-controlled trial in treated hypertensive patients already on antihypertensive medications. Results showed:

• NO reduction in home blood pressure
• NO reduction in 24-hour ambulatory blood pressure
• Despite 3-fold increase in plasma nitrate/nitrite levels
• One-week intervention with nitrate-rich beetroot juice

This suggests that beetroot supplementation does not provide additional blood pressure lowering in patients already on standard antihypertensive therapy—precisely your clinical scenario.

Dose and Duration Uncertainties:

Studies showing effects used 4, 5:

• Daily doses: 200-800 mg nitrate (equivalent to 70-250 mL beetroot juice)
• Duration: 3-60 days
• Beetroot powder dosing equivalents are poorly defined in the literature

Clinical Algorithm for Decision-Making

For an adult with uncomplicated primary hypertension on stable antihypertensive therapy:

1. Prioritize evidence-based interventions first 1, 2:

   • Optimize medication adherence (single-pill combinations preferred)
   • Implement sodium restriction (<2,300 mg/day)
   • Ensure adequate dietary potassium (3,500-5,000 mg/day from food)
   • Promote weight loss if BMI ≥25 kg/m²
   • Encourage DASH diet pattern
   • Prescribe structured exercise program

2. If blood pressure remains uncontrolled (≥130/80 mmHg) 1, 2:

   • Intensify pharmacological therapy (add third agent if on dual therapy)
   • Screen for secondary hypertension causes
   • Assess medication adherence and white-coat effect
   • Consider resistant hypertension evaluation 2

3. Beetroot supplementation consideration:

   • Not recommended as standard adjunctive therapy
   • May consider only if: patient specifically requests it, all guideline-recommended interventions optimized, patient understands limited evidence, and no contraindications exist (e.g., not taking nitrate medications for angina 7)

Important Caveats and Pitfalls

Drug Interaction Concern: Beetroot's nitrate content could theoretically interact with organic nitrates (nitroglycerin, isosorbide) used for angina, though this is not well-studied 7. The 2015 AHA statement on coronary artery disease and hypertension 7 explicitly states nitrates are not useful for hypertension management.

Powder vs. Juice: Most research used beetroot juice, not powder. The bioavailability and nitrate content of commercial beetroot powder products vary widely and are poorly standardized.

Cost-Effectiveness: Beetroot supplementation diverts resources from proven interventions. A single additional antihypertensive medication (e.g., adding chlorthalidone or amlodipine) provides far greater and more consistent blood pressure reduction 1, 2.

Tolerance Development: The 2024 meta-analysis 4 notes "no sign of development of tolerance" but acknowledges this requires further study.

Bottom Line

Focus clinical efforts on guideline-recommended lifestyle modifications and optimizing pharmacological therapy 1, 2. Beetroot powder lacks sufficient evidence for recommendation in your specific clinical scenario—a patient already on stable antihypertensive medication. The single study directly addressing this population showed no benefit 6. If blood pressure control is inadequate, intensify proven pharmacological therapy rather than adding unproven supplements.